If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.40
Bid: 4.12
Ask: 4.70
Change: 0.94 (27.09%)
Spread: 0.58 (14.078%)
Open: 3.64
High: 4.80
Low: 3.64
Prev. Close: 3.47
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Potato yield increased through PHC's Harpin

27 Jul 2012 07:00

RNS Number : 6418I
Plant Health Care PLC
27 July 2012
 



27 July, 2012

 

 

 

Plant Health Care plc

("Plant Health Care," "PHC" or "the Company")

 

POTATO YIELD INCREASED AND STORAGE LOSSES REDUCED

THROUGH PHC'S PROPRIETARY HARPIN TREATMENT

 

Plant Health Care (AIM: PHC), a leading provider of naturally derived products to the agriculture industry, announces that in recent trials it was found that potatoes, when treated with PHC's proprietary Harpin technology while still in the field, produced a 4.4% greater marketable yield at harvest and a reduced loss in long-term (7-8 month) storage from 4.6% in the untreated to 1.9% in the treated tubers. The storage improvements alone are worth about $4 per ton, which equates to $20,000 for a 5,000 ton storage building. These results were achieved in trials conducted by independent crop consultants using commercial production practices in grower fields in Washington and Idaho.

 

Harpin technology is available for all major crops. The Harpins bind to receptors on the surface of the plant leaf, causing a reaction where the plant gears up to defend itself against disease. This is the well-documented Systematic Acquired Resistance (SAR) response, which affects the yield quality and shelf life of the crops. PHC currently has several testing agreements with major companies looking at disease control, yield increase and longer, post- harvest, shelf life achieved through the combined use of Harpin and fungicide.

 

Paul Bystrak, PHC Field Scientist, commented: "We had already seen evidence in smaller-scale studies that the long-term storability of potatoes increased following in-field Harpin treatment, so it is very encouraging to have those results verified on a larger scale. We have also demonstrated similar results in a variety of crops ranging from lettuce to citrus, so the financial savings potential for the grower should prove to be very attractive."

 

Steve Holland, a crop consultant who conducted several of the trials, commented:"The growers we worked with in the Columbia Basin have become extremely proficient at storing potatoes, so it was heartening to see the additional benefits realized by the use of Harpin in storage. In addition, substantial benefits were also realized in each of the other trials that were focused solely on studying the yield benefits."

 

~ ENDS ~

 

 

 

For further information please contact:

 

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Stephen Weaver, Finance Director

Tel: +1-412-826-5488 x151

sweaver@planthealthcare.com

Nomura Code Securities

Tel: +44 (0) 20 7776 1200

Clare Terlouw / Chris Golden

www.nomuracode.com

Powerscourt

Tel: +44 (0) 20 7250 1446

Paul Durman / Nick Dibden

 

 

About Plant Health Care plc:

 

Plant Health Care plc ("PHC") is a leading provider of naturally-derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 40 employees and has operations in the United States, Mexico, the United Kingdom, Spain and the Netherlands. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at agriculture industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRARFMRTMBBTBIT
Date   Source Headline
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.